Asklepios BioPharmaceutical Inc. (AskBio), a subsidiary of Bayer AG, and Touchlight, a biotechnology company pioneering enzymatic DNA production, have revised the structure of their former joint venture, Touchlight AAV.   Under the revised arrangement implemented on February 1, 2022, both parties benefit from co-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA (dbDNA) through their respective independently owned Contract Development and Manufa...